Correlation Between China International and Innovative Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China International and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China International and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China International Capital and Innovative Medical Management, you can compare the effects of market volatilities on China International and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China International with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of China International and Innovative Medical.

Diversification Opportunities for China International and Innovative Medical

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between China and Innovative is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding China International Capital and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and China International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China International Capital are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of China International i.e., China International and Innovative Medical go up and down completely randomly.

Pair Corralation between China International and Innovative Medical

Assuming the 90 days trading horizon China International is expected to generate 8.64 times less return on investment than Innovative Medical. But when comparing it to its historical volatility, China International Capital is 1.48 times less risky than Innovative Medical. It trades about 0.0 of its potential returns per unit of risk. Innovative Medical Management is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  743.00  in Innovative Medical Management on September 3, 2024 and sell it today you would earn a total of  146.00  from holding Innovative Medical Management or generate 19.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

China International Capital  vs.  Innovative Medical Management

 Performance 
       Timeline  
China International 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in China International Capital are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China International sustained solid returns over the last few months and may actually be approaching a breakup point.
Innovative Medical 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

China International and Innovative Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China International and Innovative Medical

The main advantage of trading using opposite China International and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China International position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.
The idea behind China International Capital and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance